| Title : New advances in clinical application of neostigmine: no longer focusing solely on increasing skeletal muscle strength - Si_2023_Front.Pharmacol_14_1227496 |
| Author(s) : Si S , Zhao X , Su F , Lu H , Zhang D , Sun L , Wang F , Xu L |
| Ref : Front Pharmacol , 14 :1227496 , 2023 |
|
Abstract :
Neostigmine is a clinical cholinesterase inhibitor, that is, commonly used to enhance the function of the cholinergic neuromuscular junction. Recent studies have shown that neostigmine regulates the immune-inflammatory response through the cholinergic anti-inflammatory pathway, affecting perioperative neurocognitive function. This article reviews the relevant research evidence over the past 20 years, intending to provide new perspectives and strategies for the clinical application of neostigmine. |
| PubMedSearch : Si_2023_Front.Pharmacol_14_1227496 |
| PubMedID: 37601044 |
Si S, Zhao X, Su F, Lu H, Zhang D, Sun L, Wang F, Xu L (2023)
New advances in clinical application of neostigmine: no longer focusing solely on increasing skeletal muscle strength
Front Pharmacol
14 :1227496
Si S, Zhao X, Su F, Lu H, Zhang D, Sun L, Wang F, Xu L (2023)
Front Pharmacol
14 :1227496